Improved prognosis of young patients with breast cancer undergoing breast‐conserving surgery.
Published: 9th August 2017
Authors: E. Botteri, P. Veronesi, J. Vila, N. Rotmensz, V. Galimberti, M. V. Thomazini et al.
The aim of the present study was to evaluate how breast cancer prognosis has evolved over time in young women treated with breast‐conserving surgery (BCS).
Data from patients younger than 40 years who had BCS and whole‐breast radiotherapy in a single cancer centre between 1997 and 2010 were analysed. The patients were followed until 2016. Endpoints were local recurrence, any breast cancer‐related event and death from any cause.
A total of 1331 patients were included in the study. After a median follow‐up of 9·3 years, 114 local recurrences, 289 breast cancer‐related events and 138 deaths had occurred. Women were divided into three groups of similar size based on tertiles of the date of diagnosis: 1997–2002 (524 patients), 2003–2005 (350) and 2006–2010 (457). The risk of local recurrence was 1·42 per 100 person‐years in women diagnosed in the first interval, 0·85 per 100 person‐years in the second and 0·48 per 100 person‐years in the third (
In the past two decades, both local control and overall prognosis have improved significantly in young women (aged less than 40 years) with breast cancer who undergo BCS.Read more
You may also be interested in
Risk of death from breast cancer after treatment for ductal carcinoma in situ. BJS 2017; 104: 1506-1513.
Authors: C. Wadsten, H. Garmo, I. Fredriksson, M. Sund, F. Wärnberg
Notes: Rare, but worse for large tumours and uncertain margins
Nomograms for preoperative prediction of axillary nodal status in breast cancer. BJS 2017; 104: 1494-1505.
Authors: L. Dihge, P.‐O. Bendahl, L. Rydén
Notes: Defines need for staging?
Authors: J. R. Benson, S. K. Down
Authors: R. V. Dave, R. Millican‐Slater, D. Dodwell, K. Horgan, N. Sharma
Notes: Mid‐neoadjuvant chemotherapy MRI useful
Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy. BJS 2017; 104: 1188-1196.
Authors: B. B. Koolen, M. Donker, M. E. Straver, M. E. M. van der Noordaa, E. J. T. Rutgers, R. A. Valdés Olmos et al.
Notes: Reduced axillary lymph node dissection rates
Quality of life after mastectomy with or without immediate breast reconstruction. BJS 2017; 104: 1197-1206.
Authors: J. Dauplat, F. Kwiatkowski, P. Rouanet, E. Delay, K. Clough, J. L. Verhaeghe et al.
Notes: Good for the appropriate patient
Authors: C. Liedtke, H.‐C. Kolberg
Association between age and access to immediate breast reconstruction in women undergoing mastectomy for breast cancer. BJS 2017; 104: 555-561.
Authors: R. Jeevan, J. P. Browne, C. Gulliver‐Clarke, J. Pereira, C. M. Caddy, J. H. P. van der Meulen et al.
Notes: Age should not matter
Ten‐year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. BJS 2017; 104: n/a-n/a.
Authors: J. de Boniface, J. Frisell, L. Bergkvist, Y. Andersson
Notes: Axillary recurrences rare
Authors: K.‐T. Lee, S. I. Bang, J.‐K. Pyon, J. H. Hwang, G.‐H. Mun
Notes: Implants increase risk
Meta‐analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. BJS 2016; 103: 1409-1419.
Authors: A. Zada, M. C. L. Peek, M. Ahmed, B. Anninga, R. Baker, M. Kusakabe et al.
Notes: Both work
Authors: J. Brandt, S. Borgquist, M. Almquist, J. Manjer
Notes: Hypothyroidism reduces survival